The tale of multi-polar portfolios

Beiersdorf AG: Fiscal 2025

The fiscal year 2025 represented a definitive transition point for Beiersdorf AG, marking the end of the post-pandemic pricing surge and the beginning of a more complex, volume-driven competitive era. The group achieved total sales of 9,852 million euros, reflecting a moderate organic growth rate of 2.4 per cent. While this performance indicates continued resilience in a volatile macroeconomic climate, it represents a visible deceleration from the 6.5 per cent organic growth recorded in 2024. The narrative behind these figures suggests a company operating at two distinct speeds: a high-velocity dermatological unit that continues to redefine its category, and a legacy mass-market portfolio currently undergoing a significant strategic recalibration to address shifting consumer priorities.

Profitability remained a central pillar of the management briefing, with the operating result, excluding special factors, rising to 1,378 million euros. The corresponding EBIT margin improved slightly to 14.0 per cent from 13.9 per cent in the previous year, achieved through rigorous cost discipline and operational efficiencies that successfully offset rising raw material costs and unfavourable foreign exchange movements. However, the net income of Beiersdorf AG, the parent entity, decreased from 249 million euros to 206 million euros, primarily due to reduced dividend distributions from subsidiaries and a sharp increase in personnel expenses. This internal divergence highlights the pressure on the corporate centre to manage a global organisation amid rising labour costs and administrative complexity.